Philips and Compumedics pharmacy sleep therapy partnership
January 29, 2025
PHILIPS Pharmacy Sleep Services has partnered with Australian-based global medical device company, Compumedics, to provide "an end-to-end solution" enabling pharmacies to identify, test and treat patients with sleep apnoea.
The partnership will see Compumedics supply its Somfit devices and electrodes to Philips' pharmacy-based sleep program in pharmacies across Australia, to bring better care for more people.
Somfit is a lightweight, wearable device designed to collect high-quality physiological data to aid medical professionals in diagnosing sleep disorders.
Following clinician diagnosis of the Somfit results, patients can begin CPAP therapy with support from their local pharmacy.
"Our partnership with Compumedics will allow us to deploy innovative and easy-to-use technologies that identify consumers at risk of sleep apnoea," said Rahul Gundala, International Markets Business Leader, Philips Sleep & Respiratory.
"By integrating these meaningful innovations into our services, we're not only enhancing personal lives and wellbeing, but also significantly reducing the long-term burden of the disease on healthcare systems," Gundala said, adding that the company will improve access to care for communities across the country, including those in remote areas.
The above article was sent to subscribers in Pharmacy Daily's issue from 29 Jan 25To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 29 Jan 25
